Henrik Harling is a medical doctor and board certified specialist in GI Surgery. He holds a Danish Master of Science and was previously Associate Professor of Surgery at University of Copenhagen.
He is among the founders of the multidisciplinary Danish Colorectal Cancer Group and Association of Danish Multidisciplinary Cancer Groups, previous chairman of the Danish Colorectal Cancer Register and Executive Board Member of the Danish Cancer Society. He has undertaken treatment of cancer patients and cancer research for more than 30 years, and has published 120 scientific papers in peer reviewed journals besides guidelines and textbook chapters. He served as Head of GI-Surgery, Gastroenterology & Hepatology at Bispebjerg University Hospital in Copenhagen 2000-2016. Afterwards he joined the Danish biotech company 2cureX, from 2019 as Chief Medical Officer heading the company´s clinical trials within Functional Precision Medicine.
